m+Medelevator.RU
← Поиск публикаций
MedComm · 2026

The Multifaceted Role of Pyroptosis: Molecular Mechanisms, Crosstalk with Other Cell Death Pathways, and Therapeutic Implications.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Boaru Diego Liviu, De Castro-Martinez Patricia, Garcia-Montero Cielo, Fraile-Martinez Oscar, Alhaddadin Majd N Michael, Barrena-Blázquez Silvestra, Lopez-Gonzalez Laura, Fernández Clara Tasende, Alvarado-Hurtado Ricardo, Giménez Tomás Ratia, Lasa-Unzúe Inmaculada, Alonso Manuel Díez, Gutiérrez-Calvo Alberto, Saez Miguel A, Cobo-Prieto David, Saz Jose V, Alvarez-Mon Melchor, Diaz-Pedrero Raul, Ortega Miguel A

Аннотация

Pyroptosis is a tightly regulated, proinflammatory form of programmed cell death defined by gasdermin-mediated membrane pore formation and cytokine release. By coupling cell death to innate immune activation, pyroptosis occupies a unique position at the interface of host defense and tissue pathology. Recent advances have demonstrated that pyroptosis is activated through multiple molecular routes, including canonical and noncanonical inflammasome pathways, Caspase-3/8-gasdermin axes, and granzyme-dependent mechanisms. Importantly, pyroptosis does not operate in isolation but engages in extensive crosstalk with other programmed cell death modalities, such as apoptosis, necroptosis, ferroptosis, NETosis, and the integrative process of PANoptosis, sharing key regulators including caspases, inflammasomes, and gasdermins. Despite rapid progress, a unified framework integrating pyroptosis-specific mechanisms with interaction networks, temporal dynamics, and disease relevance is still lacking. In this review, we systematically dissect the molecular pathways governing pyroptosis, emphasize its functional interplay with other cell death programs, and discuss emerging concepts such as cell-type specificity and sublytic versus lytic outcomes. We further examine the contribution of pyroptosis to cancer, infectious, autoimmune, metabolic, and cardiovascular diseases, and critically evaluate therapeutic strategies aimed at either inhibiting excessive pyroptosis or exploiting it for immunogenic cell death. Collectively, this review offers a perspective-enhancing, mechanistic, and translational significance.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты